Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 11.20% vs -16.89% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 25.15% vs -7.03% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 53.62% vs 245.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is -6.01% vs 4.43% in Mar 2024
Compare Balance Sheet Results of Aarey Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
28.45
11.88
16.57
139.48%
Share Warrants & Outstandings
Total Reserve
107.51
24.76
82.75
334.21%
Shareholder's Funds
138.48
38.00
100.48
264.42%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
1.99
5.29
-3.30
-62.38%
Secured Loans
1.99
5.23
-3.24
-61.95%
Unsecured Loans
0.00
0.06
-0.06
-100.00%
Deferred Tax Assets / Liabilities
0.92
0.77
0.15
19.48%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.48
-0.48
-100.00%
Total Non-Current Liabilities
2.91
6.53
-3.62
-55.44%
Current Liabilities
Trade Payables
102.54
15.25
87.29
572.39%
Other Current Liabilities
11.07
3.33
7.74
232.43%
Short Term Borrowings
32.87
0.34
32.53
9,567.65%
Short Term Provisions
2.73
1.54
1.19
77.27%
Total Current Liabilities
149.21
20.46
128.75
629.28%
Total Liabilities
290.59
65.00
225.59
347.06%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
39.10
28.26
10.84
38.36%
Less: Accumulated Depreciation
22.88
7.70
15.18
197.14%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
16.22
20.56
-4.34
-21.11%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
2.12
3.00
-0.88
-29.33%
Long Term Loans & Advances
6.64
2.05
4.59
223.90%
Other Non Current Assets
0.01
1.28
-1.27
-99.22%
Total Non-Current Assets
24.98
26.89
-1.91
-7.10%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
45.48
10.42
35.06
336.47%
Sundry Debtors
133.46
16.68
116.78
700.12%
Cash and Bank
1.47
1.56
-0.09
-5.77%
Other Current Assets
0.78
0.09
0.69
766.67%
Short Term Loans and Advances
84.41
9.36
75.05
801.82%
Total Current Assets
265.61
38.10
227.51
597.14%
Net Current Assets (Including Current Investments)
116.40
17.64
98.76
559.86%
Total Current Assets Excluding Current Investments
265.61
38.10
227.51
597.14%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
290.59
65.00
225.59
347.06%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
34.86
5.62
29.24
520.28%
Book Value per share (adjusted)
46.90
30.84
16.06
52.08%
Annual - Borrowings
Borrowings 34.86 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.20% vs -16.89% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 16.22 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 25.15% vs -7.03% in Mar 2024
Annual - Investments
Investments 2.12 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 53.62% vs 245.00% in Mar 2024
Annual - Current Assets
Current Assets 265.61 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -6.01% vs 4.43% in Mar 2024






